Dr. Lykissa uses state of the art equipment called an ICP-MS (which
can detect platinum in parts per billion) and an Ion Chromatograph (to
determine ionization). It is recognized by the scientific community
that "platinum salts" (aka chloroplatinic acid) can cause systemic
disease in humans as a result of toxic and/or hypersensitivity
reactions. These toxic and hypersensitivity reactions can range from
asthma, rhinorrhea, tinnitus, conjunctivitis, urticaria, fatigue
syndrome secondary to impaired oxygen exchange, neurotoxicity, sicca
syndrome, and macular rashes.
Dr. Ray Biagini, Director Research Scientist/Research Toxicologist at
CDC/NIOSH states that soluble salts of platinum are the most potent
chemical sensitizers known to man.
Dow do***ents indicate chloroplatinic acid 3-8015 INT (PLATNM2) was
used in mammary implant material formulation. Dow notified the EPA
Office of Pollution Prevention and Toxics of substantial risk in a
guinea pig sensitization study of Dow Corning 3-8015 Intermediate
(Platinum #2) on 12/27/96. Dow apparently convinced the FDA in a
meeting on 3/18/97 that any platinum that leaked from breast implants
was harmless and in small amounts.
Published German Research (2003) using ICP-HR-IDMS states "the
highest concentration (of platinum) was found in the fat tissue from
woman A who had a "bleeding" implant. In the fibrin layer of womanC,
a higher platinum concentration was registered than in her capsule
tissue. The tenfold higher platinum concentration in the fibrin layer
may also indicate the migration of this element through an intact
implant envelope."
The CDC tested the urine of 1,007 randomly selected people from the
general population for platinum and did not find significant levels of
platinum. However their current analytic methods are capable of only
measuring platinum concentrations as low as 0.04 micrograms (mcg) per
liter in urine.
Because the medical community does not recognize platinum poisoning
from implants, we do not have good research on how the platinum might
be removed.
Marlene Keeling
Chemically Assoicated Neurological Disorders
|
